Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 26.

Gautschi, Oliver; Rothschild, Sacha I; Li, Qiyu; Matter-Walstra, Klazien; Zippelius, Alfred; Betticher, Daniel C; Früh, Martin; Stahel, Rolf A; Cathomas, Richard; Rauch, Daniel; Pless, Miklos; Peters, Solange; Froesch, Patrizia; Zander, Thilo; Schneider, Martina; Biaggi, Christine; Mach, Nicolas; Ochsenbein, Adrian F; Swiss Group for Clinical Cancer Research (SAKK) (2017). Bevacizumab plus pemetrexed versus pemetrexed alone as maintenance therapy for patients with advanced nonsquamous non-small-cell lung cancer: Update from the swiss group for clinical cancer research (SAKK) 19/09 trial. Clinical Lung Cancer, 18(3):303-309.

Kresoja-Rakic, Jelena; Sulemani, Merve; Kirschner, Michaela B; Ronner, Manuel; Reid, Glen; Kao, Steven; Schwaller, Beat; Weder, Walter; Stahel, Rolf A; Felley-Bosco, Emanuela (2017). Posttranscriptional regulation controls calretinin expression in malignant pleural mesothelioma. Frontiers in Genetics, 8:70.

Bubendorf, Lukas; Dafni, Urania; Schöbel, Martin; Finn, Stephen P; Tischler, Verena; Sejda, Aleksandra; Marchetti, Antonio; Thunnissen, Erik; Verbeken, Eric K; Warth, Arne; Sansano, Irene; Cheney, Richard; Speel, Ernst Jan M; Nonaka, Daisuke; Monkhorst, Kim; Hager, Henrik; Martorell, Miguel; Savic, Spasenija; Kerr, Keith M; Tan, Qiang; Tsourti, Zoi; Geiger, Thomas R; Kammler, Roswitha; Schulze, Katja; Das-Gupta, Ashis; Shames, David; Peters, Solange; Stahel, Rolf A (2017). Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: results from the European Thoracic Oncology Platform (ETOP) Lungscape project. Lung Cancer, 111:143-149.

Peters, Solange; Stahel, Rolf A; Dafni, Urania; Aix, Santiago Ponce; Massutí, Bartomeu; Gautschi, Oliver; Coate, Linda; López Martín, Ana; van Heemst, Robbert; Berghmans, Thierry; Meldgaard, Peter; Cobo Dols, Manuel; Noguera, Javier Garde; Curioni-Fontecedro, Alessandra; Rauch, Daniel; Mark, Michael T; Cuffe, Sinead; Biesma, Bonne; van Henten, Arjen Mj; Vidal, Óscar Juan; Sanchez, Ramón Palmero; Villa Guzmán, José Carlos; Martin, Ricardo Collado; Peralta, Sergio; Insa, Amelia; Summers, Yvonne; Láng, István; Horgan, Anne; Ciardiello, Fortunato; de Hosson, Sander; et al (2017). Randomized phase III trial of erlotinib versus docetaxel in patients with advanced squamous cell non-small cell lung cancer failing first line platinum-based doublet chemotherapy stratified by Veristrat good versus Veristrat poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung trial. Journal of Thoracic Oncology, 12(4):752-762.

Negrouk, Anastassia; Lacombe, Denis; Cardoso, Fatima; Morin, Franck; Carrasco, Eva; Maurel, Joan; Maibach, Rudolf; Aranda, Enrique; Marais, Richard; Stahel, Rolf A (2017). Safeguarding the future of independent, academic clinical cancer research in Europe for the benefit of patients. ESMO Open, 2(3):e000187.

Kresoja-Rakic, Jelena; Kapaklikaya, Esra; Ziltener, Gabriela; Dalcher, Damian; Santoro, Raffaella; Christensen, Brock C; Johnson, Kevin C; Schwaller, Beat; Weder, Walter; Stahel, Rolf A; Felley-Bosco, Emanuela (2016). Identification of cis- and trans-acting elements regulating calretinin expression in mesothelioma cells. OncoTarget, 7(16):21272-21286.

Martini, Katharina; Meier, Andreas; Opitz, Isabelle; Weder, Walter; Veit-Haibach, Patrick; Stahel, Rolf A; Frauenfelder, Thomas (2016). Diagnostic accuracy of sequential co-registered PET+MR in comparison to PET/CT in local thoracic staging of malignant pleural mesothelioma. Lung Cancer, 94:40-45.

Meerang, Mayura; Bérard, Karima; Felley-Bosco, Emanuela; Lauk, Olivia; Vrugt, Bart; Boss, Andreas; Kenkel, David; Broggini-Tenzer, Angela; Stahel, Rolf A; Arni, Stephan; Weder, Walter; Opitz, Isabelle (2016). Antagonizing the hedgehog pathway with vismodegib impairs malignant pleural mesothelioma growth in vivo by affecting stroma. Molecular Cancer Therapeutics, 15(5):1095-1105.

Tabernero, Josep; Vyas, Malvika; Giuliani, Rosa; Arnold, Dirk; Cardoso, Fatima; Casali, Paolo G; Cervantes, Andres; Eggermont, Alexander Mm; Eniu, Alexandru; Jassem, Jacek; Pentheroudakis, George; Peters, Solange; Rauh, Stefan; Zielinski, Christoph C; Stahel, Rolf A; Voest, Emile; Douillard, Jean-Yves; McGregor, Keith; Ciardiello, Fortunato (2016). Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers. ESMO Open, 1(6):e000142.

Stahel, Rolf A; Riesterer, Oliver; Xyrafas, Alexandros; Opitz, Isabelle; Beyeler, Michael; Ochsenbein, Adrian; Früh, Martin; Cathomas, Richard; Nackaerts, Kristiaan; Peters, Solange; Mamot, Christoph; Zippelius, Alfred; Mordasini, Carlo; Caspar, Clemens B; Eckhardt, Katrin; Schmid, Ralph A; Aebersold, Daniel M; Gautschi, Oliver; Nagel, Wolfgang; Töpfer, Michael; Krayenbuehl, Jerome; Ribi, Karin; Ciernik, Llja F; Weder, Walter (2015). Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial. Lancet Oncology, 16(16):1651-1658.

Gautschi, Oliver; Mach, Nicholas; Rothschild, Sacha I; Li, Qiyu; Stahel, Rolf A; Zippelius, Alfred; Cathomas, Richard; Früh, Martin; Betticher, Daniel C; Peters, Solange; Rauch, Daniel; Feilchenfeldt, Jonas; Bubendorf, Lukas; Savic, Spasenija; Jaggi, Rolf; Leibundgut, Elisabeth Oppliger; Largiadèr, Carlo; Brutsche, Martin; Pilop, Christiane; Stalder, Lukas; Pless, Miklos; Ochsenbein, Adrian F (2015). Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09. Clinical Lung Cancer, 16(5):358-365.

Opitz, Isabelle; Friess, Martina; Kestenholz, Peter; Schneiter, Didier; Frauenfelder, Thomas; Nguyen-Kim, Dan Linh; Seifert, Burkhardt; Hoda, Mir Alireza; Klepetko, Walter; Stahel, Rolf A; Weder, Walter (2015). A new prognostic score supporting treatment allocation for multimodality therapy for malignant pleural mesothelioma- A review of 12 years' experience. Journal of Thoracic Oncology, 10(11):1634-1641.

Pless, Miklos; Stupp, Roger; Ris, Hans-Beat; Stahel, Rolf A; Weder, Walter; Thierstein, Sandra; Gerard, Marie-Aline; Xyrafas, Alexandros; Früh, Martin; Cathomas, Richard; Zippelius, Alfred; Roth, Arnaud; Bijelovic, Milorad; Ochsenbein, Adrian; Meier, Urs R; Mamot, Christoph; Rauch, Daniel; Gautschi, Oliver; Betticher, Daniel C; Mirimanoff, René-Olivier; Peters, Solange (2015). Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial. Lancet, 386(9998):1049-1056.

Rusch, Andreas; Ziltener, Gabriela; Nackaerts, Kristiaan; Weder, Walter; Stahel, Rolf A; Felley-Bosco, Emanuela (2015). Prevalence of BRCA-1 associated protein 1 germline mutation in sporadic malignant pleural mesothelioma cases. Lung Cancer, 87(1):77-79.

Peters, Solange; Weder, Walter; Dafni, Urania; Kerr, Keith M; Bubendorf, Lukas; Meldgaard, Peter; O'Byrne, Kenneth J; Wrona, Anna; Vansteenkiste, Johan; Felip, Enriqueta; Marchetti, Antonio; Savic, Spasenija; Lu, Shun; Smit, Egbert; Dingemans, Anne-Marie; Blackhall, Fiona H; Baas, Paul; Camps, Carlos; Rosell, Rafael; Stahel, Rolf A (2014). Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parameters. Journal of Thoracic Oncology, 9(11):1675-1684.

Blackhall, Fiona H; Peters, Solange; Bubendorf, Lukas; Dafni, Urania; Kerr, Keith M; Hager, Henrik; Soltermann, Alex; O'Byrne, Kenneth J; Dooms, Christoph; Sejda, Aleksandra; Hernández-Losa, Javier; Marchetti, Antonio; Savic, Spasenija; Tan, Qiang; Thunnissen, Erik; Speel, Ernst-Jan M; Cheney, Richard; Nonaka, Daisuke; de Jong, Jeroen; Martorell, Miguel; Letovanec, Igor; Rosell, Rafael; Stahel, Rolf A (2014). Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project. Journal of Clinical Oncology, 32(25):2780-2787.

Renganathan, Arun; Kresoja-Rakic, Jelena; Echeverry, Nohemy; Ziltener, Gabriela; Vrugt, Bart; Opitz, Isabelle; Stahel, Rolf A; Felley-Bosco, Emanuela (2014). GAS5 long non-coding RNA in malignant pleural mesothelioma. Molecular Cancer, 13:119.

Kotov, Ilya N; Siebring-van Olst, Ellen; Knobel, Philip A; van der Meulen-Muileman, Ida H; Felley-Bosco, Emanuela; van Beusechem, Victor W; Smit, Egbert F; Stahel, Rolf A; Marti, Thomas M (2014). Whole genome RNAi screens reveal a critical role of REV3 in coping with replication stress. Molecular Oncology, 8(8):1747-1759.

Nater, Harald; Niggemeier, Verena; Stahel, Rolf A; Franzen, Daniel (2013). Obere Einflussstauung – Vena-cava-superior-Syndrom. Praxis, 102(9):503-512.

Felley-Bosco, Emanuela; Opitz, Isabelle (2012). Mesothelioma. In: Stahel, Rolf A. Lung Cancer Therapy Annual 7. London: Informa Healthcare, 141-150.

Shi, Yandong; Moura, Ubiratan; Opitz, Isabelle; Soltzermann, Alex; Rehrauer, Hubert; Thies, Svenja; Weder, Walter; Stahel, Rolf A; Felley-Bosco, Emanuela (2012). Role of hedgehog signaling in malignant pleural mesothelioma. Clinical Cancer Research, 18(17):4646-4656.

Scagliotti, Giorgio; Stahel, Rolf A; Rosell, Rafael; Thatcher, Nick; Soria, Jean-Charles (2012). ALK translocation and crizotinib in non-small cell lung cancer: an evolving paradigm in oncology drug development. European Journal of Cancer, 48(7):961-973.

Shi, Yandong; Felley-Bosco, Emanuela; Marti, Thomas M; Orlowski, Katrin; Pruschy, Martin; Stahel, Rolf A (2012). Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin. BMC Cancer, 12:571.

Knobel, Philip A; Kotov, Ilya N; Felley-Bosco, Emanuela; Stahel, Rolf A; Marti, Thomas M (2011). Inhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cells. Neoplasia, 13(10):961-970.

Ziegler, Annemarie; Seemayer, Christian A; Hinterberger, Marc; Vogt, Peter; Bigosch, Colette; Gautschi, Oliver; Tornillo, Luigi; Betticher, Daniel C; Moch, Holger; Stahel, Rolf A (2007). Low prevalence of SV40 in Swiss mesothelioma patients after elimination of false-positive PCR results. Lung Cancer, 57(3):282-291.

Lardinois, Didier; Weder, Walter; Roudas, Marina; von Schulthess, Gustav K; Tutic, Michaela; Moch, Holger; Stahel, Rolf A; Steinert, Hans C (2005). Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer. Journal of Clinical Oncology, 23(28):6846-6853.

This list was generated on Wed Sep 19 02:57:17 2018 CEST.